Commure Hits $7B Backed by GC, Sequoia, Morgan Stanley
- 01The "Work Tax" in Healthcare Is a Trillion-Dollar Opportunity
- 02Platform Consolidation Will Kill Point Solutions
- 03Non-Dilutive Capital Structures Are a Competitive Moat
Episode: Commure Hits $7B Backed by GC, Sequoia, Morgan Stanley Podcast: Sourcery Participants: Molly O'Shea (CEO, Commure), Tanay Tandon (Host)
1. Key Themes
The "Work Tax" in Healthcare Is a Trillion-Dollar Opportunity
Healthcare administration costs approximately $1 trillion annually in clinical and financial admin alone. Commure's thesis is that LLMs are uniquely suited to eliminate this "work tax" at scale, transforming health systems from 2-3% operating margins to 20-30% operating margins.
"There's a trillion dollars spent on healthcare admin every year. That's clinical admin. That's financial admin, like revenue cycle management. All of the tasks that happen in the back office of a health system, like scheduling, prior auth appeals. We've built a series of fine-tuned language models and agents that automate all of those tasks." 00:08:15
"LLMs are this gift that we've received to go nuke all of that work tax. And that, in some ways, is going to be my life's work in terms of just eliminating the work tax and making the system a trillion dollars more efficient. Because if you do that, then you make the entire American middle class wealthier." 00:55:23
Platform Consolidation Will Kill Point Solutions
The central strategic bet is that in every technology paradigm shift, platforms eventually displace point solutions. Commure is building the unified OS rather than individual tools, believing this is where ultimate ACV capture occurs.
"When we launch our platform in a 100-provider practice, the first thing we do is we displace the point solution scribe that they're using. And so that company's revenue just went to zero. And our revenue just went up by, you know, a factor of 10 on the account." 00:15:06
"In the 80s and 90s, there was a software that came out called Grammatic. And it was an autocorrecting tool. And everybody loved it. And then Microsoft Word came out with autocorrect as part of the software. And this company's revenue went to zero... these point solution businesses either have to turn into platforms very quickly or they die." 00:15:35
Non-Dilutive Capital Structures Are a Competitive Moat
General Catalyst's Customer Value Fund (CVF) enables Commure to fund go-to-market expansion using forward-looking revenue cohorts rather than balance sheet equity — keeping dilution minimal while accelerating growth.
"CVF is built to address that need very, very particularly, which is instead of risking against balance sheet, it's risk against forward-looking customer cohorts and performance. So if you're confident that your SaaS cohorts will perform and revenue will show up, you can essentially forward pull that revenue to fund expansion faster and faster." 00:05:04
"You actually don't want to use balance sheet for go-to-market. You want to use balance sheet for R&D and these more durable long-term investments. And that's why we used it, and I think that's why it's an amazing vehicle." 00:05:34
2. Contrarian Perspectives
Healthcare Needs Business Operators, Not Politicians, at the Helm
Most people frame healthcare's problems as structural or systemic. Molly's view is more direct: the real problem is that healthcare systems are run by committee-oriented administrators rather than aggressive business operators, and the fastest-growing systems prove this.
"Healthcare's biggest problem today is it is run by politicians. It is not run by ruthless, pragmatic business operators. And if you look at the for-profit institutions that are growing the fastest, that are compounding the fastest for shareholders and for patients, this single trend that's shared amongst all of them is you have amazing aggressive CEOs at the top as opposed to design by committee and decide by committee." 00:10:19
AI Will Reduce Malpractice Exposure, Not Increase It
Conventional wisdom assumes AI in healthcare creates liability risk. Molly argues the opposite: on average, AI improves outcomes enough that CFOs and CLOs are enthusiastic, and it will likely reduce insurance premiums over time.
"When we talk to health system C-suite, the CFOs and the CLOs are like so excited because they see in the data, just like with self-driving, that yes, occasionally you have weird performance. But on the averages and in the 99% of cases, it improves outcomes so much that the malpractice implications are actually very net positive." 00:23:10
The American Healthcare System Is Actually the Best in the World
The prevailing narrative is that American healthcare is broken compared to universal systems. Molly flips this entirely, arguing that U.S. healthcare is the global innovation engine and that comparative systems are fundamentally inferior in care quality.
"This idea that you can get the same quality of care in Canada or in the U.K. is preposterous. I mean, you're waiting in lines for a basic primary care visit for a year in the U.K. The American healthcare system is quite advanced... the quality of the system is probably the highest in the world. And now it's just a matter of LLMs are this gift that we've received to go nuke all of that work tax." 00:54:53
Good M&A Requires Embracing Skeletons, Not Seeking Pristine Assets
Standard M&A advice focuses on thorough diligence to find clean assets. Molly argues the opposite: pristine assets have no price disparity, so real value creation comes from acquiring imperfect assets and fixing them.
"Pristine assets are usually, there's no price disparity. There's no advantage that you can take of a pristine asset. Most M&A, and I think most good M&A, there are skeletons. There are things that you have to internalize that are not working in the company and be okay with that because you have the other pieces that will make it work." 00:41:36
Culture Integration Must Be Ruthless, Not Collaborative
The popular narrative around M&A integration emphasizes blending cultures. Molly argues this is a trap — there must be one winning culture, and leaders who soften this reality slow down integration and damage the combined business.
"This idea of you acquire companies and everyone's friends and we're going to be a little bit of your culture, a little bit of our culture. No, there's always a winning acquiring culture that becomes the culture of the combined business. And there are people in the company you're acquiring that heavily opt into that. There's also people that opt out and that's totally fine." 00:42:34
3. Companies Identified
Commure AI-powered operating system for healthcare providers, combining ambient documentation, autonomous coding, revenue cycle management, patient engagement, and back-office automation into a single platform. Mentioned as the subject company, having reached $7B valuation, 200M patient encounters annually, $750M raised, 1,200 employees, and saving 75M physician hours per year.
"Today a practice that uses our platform will use us for their scribing, their practice management, their documentation, their autonomous coding, their revenue cycle, and all of their back office needs." 00:08:38
HCA Healthcare One of the largest for-profit health systems in the U.S., with 185 hospitals and 2,000 ambulatory sites, generating north of $100B in revenue. Mentioned as a flagship Commure enterprise partner where implementation is driving measurable physician productivity gains at scale.
"In health systems like HCA, we've been able to add a couple hours to every physician's day. And this is a company that generates north of $100 billion in top-line revenue. So if you can add even a couple percentage points of juice to that, that is billions of dollars of operating cash flow." 00:09:21
SUMA Health (Akron, Ohio) A real hospital in Akron, Ohio acquired by General Catalyst from near-bankruptcy as a live demonstration of AI-native healthcare transformation. Mentioned as an extraordinary proof-of-concept where Commure tools are being deployed alongside GC's Health Assurance framework.
"The beauty of GC and Hemant is we are so ambitious and they are not content being a VC firm that just makes great returns for LPs. They really want to bend the universe. And part of that means going to Akron, Ohio, buying a system that was on track to go bankrupt and transforming it with AI." 00:28:50
Meditech & Epic The two dominant EMR platforms in healthcare. Mentioned as critical distribution partners for Commure, enabling embedded activation of Commure tools directly within physician workflows rather than requiring displacement.
"We have a deep relationship with Meditech, as well as a really close relationship with Epic, where we're a toolbox partner. And at the press of a button, an Epic physician can turn on Commure Ambient, start using it." 00:12:50
General Catalyst Tier-1 venture firm and lead investor in Commure. Mentioned specifically for its non-conventional capital vehicles (CVF), its Health Assurance platform strategy, and its willingness to directly operate a hospital (SUMA) to prove the thesis.
"The best investors are so plugged in that they're meeting with the random autistic kid on campus and giving them time of day. When HT was already running Livongo and already a big-time investor in Stripe." 00:53:27
ADOC An imaging-based company automating scan processes, deployed at SUMA alongside Commure. Briefly mentioned as part of the AI transformation stack being showcased to RFK Jr. at SUMA.
"We hosted him there and it was an amazing visit, showing him the transformation with ambient documentation on Commure Stack with ADOC, which is an imaging-based company that's essentially automating a lot of the scan process." 00:29:20
4. People Identified
Molly O'Shea CEO and co-founder of Commure. Started the company at 18, previously at the Stanford AI lab. Built a $7B healthcare AI company through M&A, enterprise sales, and deep partnership with health systems.
"I was at the Stanford AI lab. I thought I would be a hacker my whole life. I thought I would get a PhD. I thought I would go work at a research lab. And that would have been a fun career too. This is just a very different set of skills." 00:47:53
Hemant Taneja (HT) Managing Director and CEO of General Catalyst. Mentioned for his vision to bend the healthcare system at scale, his willingness to invest time in unknown founders early, and his direct involvement in transforming SUMA hospital.
"I got to hand it to Hemant. The beauty of GC and Hemant is we are so ambitious and they are not content being a VC firm that makes just great returns for LPs by investing in a Series A. They really want to bend the universe." 00:28:50
Alfred Lin Partner at Sequoia Capital, former COO/CFO at Zappos. Mentioned for his unusually analytical operating lens as an investor, his role as a closer in competitive talent recruiting, and his hands-on engagement at the P&L level.
"Alfred is so analytical. When you show him a P&L, he will scrutinize everything down to the last item. Like why was T&E on sales and enterprise and the Western segment so high this quarter? His instincts are very sharp." 00:50:29
"Whenever we've had a candidate that we are right there at the finish line and we're competing with a larger company or a larger comp offer, Alfred comes in and gets the job done." 00:51:25
Teresa Carlson Board member at Commure, former AWS executive who led government cloud transformation including the CIA deal. Mentioned for her counsel on government engagement, her legendary enterprise sales instincts, and her direct operating parallels to Commure's health system transformation work.
"Nobody shoots whiskey like Teresa. And the woman is truly a legend. They went to the CIA. And they told them, you guys are going to turn into cloud-first, cloud-native organizations. And she did it in partnership with Jassy and the whole team there." 00:17:43
Deepika Co-founder of Commure. Described as an exceptional enterprise saleswoman with strong interpersonal instincts, instrumental in early partnerships and company building.
"Deepika was like a saleswoman. She's really good at getting into situations, talking her way into things, out of things." 00:45:48
Chris Klomp Government official leading healthcare innovation initiatives in the current administration. Mentioned as a breath of fresh air, an innovator in a government chair, advancing healthcare interoperability and data liquidity reform.
"Folks like Chris Klomp, who's come in and is leading a lot of those initiatives, are just a breath of fresh air. And to see innovators in government positions — I think most people don't realize how forward thinking this admin is." 00:34:54
5. Operating Insights
The Palantir Forward-Deployed Engineer Model Accelerates Enterprise AI Adoption
Commure explicitly adopted Palantir's forward-deployed engineer model to embed smart, hungry engineers directly inside hospitals and health systems. This creates co-development loops with physicians, dramatically accelerating adoption compared to traditional software deployment.
"We have this forward deployed team of engineers that, obviously stolen from Palantir, but the model works so well. You take smart, hungry people that are early in their careers and you throw them into the face of the problem within the hospital, within the health system. And you kind of let them free." 00:24:11
The result: physician-engineer co-development sessions drove expansion from 3 physicians to enterprise-wide HCA rollouts. Training cycles for end users collapse to one to one-and-a-half days because the model is built around actual clinical workflows, not assumed ones.
Use Wedge Products to Enter, Platform to Capture
The dual go-to-market motion — fast-moving point solutions as wedge, followed by full platform sell — is a deliberate and disciplined strategy to balance speed of logo acquisition with long-term ACV capture. The key discipline is ensuring both motions reinforce rather than cannibalize each other.
"Our strategy has been twofold, which is have a series of point solutions like ambient documentation, autonomous coding, intake, that can be those wedge products that enter a health system and allow for quick adoption. And then the platform sell, which quickly follows, but might be a 12-month sales cycle or longer, a 24-month sales cycle for the larger health systems. But contracts that are worth tens of millions of dollars at the tail end of it." 00:13:48
45-Day Culture Reset Window in M&A Is Non-Negotiable
Post-acquisition integration must move fast and decisively. The window to establish the acquiring culture is 45 days to set the tone, 90 days maximum before the old culture calcifies. Leaders who soften this reality allow legacy operating patterns to persist indefinitely.
"You have like 45 days is like kind of set. Like people are now, they know what they're doing. They're either locked in or they're not. And by day 90, if that reset hasn't happened, you're going to continue to run the business the way it was running before, which probably isn't a good thing." 00:42:39
6. Overlooked Insights
Data Interoperability Reform Is Quietly Unlocking a Competitive Moat for AI-Native Entrants
This was mentioned briefly in the context of the current administration's policy moves, but the implications are enormous. Epic and other EMRs have historically weaponized data lock-in as a competitive barrier — charging fees to move data and blocking integrations. The current administration is actively defunding this behavior via the Cures Act and Department of Justice enforcement. For AI-native platforms like Commure, this isn't just regulatory relief — it's a structural collapse of the moat that protected incumbents for decades.
"This is insane. If I want to move data from one place in Salesforce to another place in Salesforce, I can do it with my eyes closed. If I want to do that in Epic, I got to go sacrifice my firstborn child to Judy. And so data liquidity is like a very real problem in healthcare. And I think the admin is tackling it head on. They're funding the Department of Justice to come after folks that are engaging in information blocking or violating the Cures Act." 00:33:06
Any company building on top of healthcare data should treat this regulatory shift as a material tailwind, and any investment thesis in healthcare AI should factor in accelerating data accessibility as a core unlock.
AI Cash Flow Flywheel Enables Health Systems to Self-Fund R&D — Reducing Dependence on Vendors
Buried in the SUMA discussion is a profound structural insight: Commure's model is designed so that the efficiency gains it delivers generate operating cash flow, which health systems then reinvest in internal AI R&D teams — teams that co-build with Commure. This creates a compounding flywheel where the vendor and the health system become increasingly co-dependent, making displacement nearly impossible for competitors.
"Step one, give them the tools that improve cash flow. And then that cash flow lets them invest in R&D teams who will then go build more and more interesting stuff in partnership with us within the hospital and within the system." 00:28:00
This is not a typical SaaS dynamic — it's closer to a platform ecosystem play where the customer becomes a co-developer, dramatically increasing switching costs and deepening the moat over time.